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Abstract
Background: This study aimed to investigate groups of patients with a relatively homogenous
health status to evaluate the degree to which use of the Australian hospital system is affected by
socio-economic status, locational accessibility to services and patient payment classification.
Method: Records of all deaths occurring in Western Australia from 1997 to 2000 inclusive were
extracted from the WA mortality register and linked to records from the hospital morbidity data
system (HMDS) via the WA Data Linkage System. Adjusted incidence rate ratios of hospitalisation
in the last, second and third years prior to death were modelled separately for five underlying
causes of death.
Results: The independent effects of socioeconomic status on hospital utilisation differed markedly
across cause of death. Locational accessibility was generally not an independent predictor of
utilisation except in those dying from ischaemic heart disease and lung cancer. Private patient status
did not globally affect utilisation across all causes of death, but was associated with significantly
decreased utilisation three years prior to death for those who died of colorectal, lung or breast
cancer, and increased utilisation in the last year of life in those who died of colorectal cancer or
cerebrovascular disease.
Conclusion: It appears that the Australian hospital system may not be equitable since equal need
did not equate to equal utilisation. Further it would appear that horizontal equity, as measured by
equal utilisation for equal need, varies by disease. This implies that a 'one-size-fits-all' approach to
further improvements in equity may be over simplistic. Thus initiatives beyond Medicare should be
devised and evaluated in relation to specific areas of service provision.
Background
Australia has a universal publicly funded system of health
care (Medicare), which operates in tandem with an
optional 'opt up' private health sector. A principal objec-
tive of Medicare is to remove, or at least reduce, financial
barriers to access to health care for all Australian residents
[1]. The system is designed so that health services are
accessible based on need regardless of social, locational or
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financial status. Such universal health insurance systems
are expected to be equitable; however, a survey of commu-
nity perceptions of the health systems in five countries,
including Australia, found that the problems experienced
by lower income groups in accessing health care persisted
even in the presence of universal health insurance cover-
age [2].
Studies have shown that variations in service provision are
often poorly explained by variations in need [3]. This phe-
nomenon has been coined the 'inverse care law'[7], first
described by Tudor Hart in 1971, whereby the availability
of medical care tends to vary inversely with the need for it
in the population served [7].
Numerous studies have indicated that distance to health
care services is inversely associated with utilisation [4-6].
In Australia, Jong et al [8] found that people living in
remote and rural areas had limited access to health serv-
ices compared with those living in the metropolitan areas.
Important contributing factors included geographic isola-
tion, poor transport links, shortage of health care provid-
ers and an overall lower socioeconomic status. The
authors found that in NSW people living in remote areas
diagnosed with cancer were approximately 35% more
likely to die as a result of their cancer over the ensuing five
years compared with those living in metropolitan areas
[8].
The 'inverse care law' is not followed consistently by the
evidence in relation to socioeconomic disadvantage. Stud-
ies investigating the use of health services typically report
that socially disadvantaged groups have higher levels of
hospital admissions and medical consultations, but make
less use of preventative and screening services [9]. This
relationship has largely been explained by health status,
whereby morbidity and premature mortality are dispro-
portionately concentrated among the socioeconomically
disadvantaged [9]. Thus, all things being equal, those with
greatest need, and the socioeconomically disadvantaged,
should have the greatest utilisation in an equitable health
system.
Since equity (strictly speaking horizontal equity) in health
care can be defined as equal treatment for equal need [10],
the degree to which utilisation of the Australian hospital
system is affected by socioeconomic status, locational
accessibility and private admission status (the two tier sys-
tem), once needs are taken into account, is a measure of
its (horizontal) equity. However, the independent effects
of socio-economic status, locational accessibility to serv-
ices and private patient status on hospital utilisation rates
have to date been difficult to evaluate due to confounding
by severity of illness and comorbidity [11-14].
This study aimed to adjust for severity of illness by inves-
tigating groups of patients with relatively homogenous
health status to evaluate the extent to which rates of hos-
pital utilisation varied across socio-economic status, loca-
tional accessibility to services and private patient status
when adjusted for likely confounding factors such as age,
gender, race and comorbidity.
Methods
Sources of data
Records of all deaths occurring in Western Australia from
1997 to 2000 inclusive were extracted from the WA mor-
tality register. For each decedent, linked records were
extracted from the hospital morbidity data system
(HMDS) via the WA Data Linkage System [15]. For each
individual the linked data set comprised the following
fields:
￿ From the mortality register: encrypted patient identifica-
tion, age, gender, Aboriginality, cause of death, date of
death and residential location recorded as postcode and
collector's district (where available).
￿ From the HMDS: encrypted patient identification and
episode number, age, gender, Aboriginality, residential
location recorded as postcode and collector's district
(where available), date of admission, date of separation,
ICD code of principal and additional diagnoses, ICD code
of principal and additional procedures, hospital type
(public, private, commonwealth, other) and the payment
classification recorded for each admission.
Episodes of care involving transfers between hospitals
were identified for each individual in the data set using
the separation and admission dates to define temporally
contiguous records. These were counted as only one hos-
pital episode. For the purposes of assigning indices of
socioeconomic status, locational accessibility to services
and payment classification to hospital episodes, the rele-
vant data assigned to the first hospital record in a transfer
set was the one used to assign the indices for that entire
episode of care.
Case selection and stratification
Cases were selected for the study and stratified for separate
analyses according to the underlying cause of death
recorded on the mortality record. The five causes of death
selected for the study were colorectal cancer, lung cancer,
female breast cancer, ischaemic heart disease and cerebro-
vascular disease. The selection was based on national pri-
orities and leading causes of death.
Assignment of socioeconomic status
An index of socioeconomic disadvantage was determined
for each episode of care by transformation of the collec-BMC Health Services Research 2006, 6:74 http://www.biomedcentral.com/1472-6963/6/74
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tor's district (cd), or postcode where cd was unavailable,
into numeric values of social disadvantage using the
SEIFA (Socioeconomic Indices for Areas) index of relative
disadvantage [16] based on Census data for 1996. An
index of relative socioeconomic status for WA was con-
structed by partitioning the continuous SEIFA values into
quintiles to create five ordinal categories: highly advan-
taged, advantaged, average, disadvantaged, and highly
disadvantaged.
Assignment of locational accessibility to services
A locational accessibility index for each episode of care
was constructed using the Accessibility and Remoteness
Index of Australia (ARIA) based on cd and postcodes [17].
ARIA measures accessibility to services using point loca-
tion of service centres and distances by road. The classifi-
cation system was that recommended by the
Commonwealth Department of Health and Aged Care
[18] and grouped the continuous ARIA values into five
ordinal categories: major city (highly accessible), inner
regional (accessible), outer regional (moderately accessi-
ble), remote and very remote.
Assignment of private patient status
Private patient status was assigned based on the payment
classification of each episode of care (public or private).
Those episodes receiving a payment classification of work-
ers compensation, motor vehicle insurance, defence force
personnel and Veteran Affairs were grouped as 'other'.
Individuals who had no HMDS records in a particular
look-back period were classified as 'no hospital admis-
sion' and their payment status for that look-back period
was assigned either based upon that of the previous
HMDS record, or that of the first HMDS record, if there
were no previous records. Those with no HMDS records in
any look-back period were assigned to the public payment
classification.
Assignment of age at death groups
Individuals were assigned to one of five age at death
groups (20 years and under, 21 to 40 years, 41 to 60 years,
61 to 80 years and 81 years and over) determined by their
age at death recorded on the mortality register. These age
groups were chosen because the outcomes being exam-
ined were chronic conditions whose manifestations typi-
cally occur in middle to late adulthood. Thus children and
very young adults were grouped together as were the old-
est old. Since the effect age per se was not being studied in
the analysis, but age related confounding was likely,
broad age groups were chosen to simplify the analysis and
improve cell counts.
Assignment of comorbid conditions
The recorded principal and additional diagnoses and pro-
cedures were used to assign co-morbid status (yes/no) to
each episode of care. This was based on the observation of
any of 17 co-morbid conditions [19], excluding those that
came under the classification of the recorded cause of
death, within 12 months of the date of admission for each
particular episode of care.
Partition of records, enumeration of total episodes of care 
and calculation of time at risk
For each individual the total number of episodes of care
in the last year of life and the second and third years prior
to death were calculated separately and recorded on the
first (index) record within each look-back period. The
number of days at risk for each individual within each
look-back period was calculated and recorded on the
index record by subtracting the total in-patient time in
days (inclusive of transfer events) from the maximum
available time at risk (365 days). The relevant index
records, containing data on cause of death, gender, indig-
enous status, co-morbid binary (yes/no) indicator, age
group at death, type of hospital, SEIFA category, ARIA cat-
egory and admission status were partitioned from the
master data set and used as input into the modelling proc-
ess.
Modelling the incidence rate ratio
After analysing the structure of the data for model appro-
priateness, negative binomial maximum-likelihood
regression (last year of life) and the general linear model
using a negative binomial variance function and a log link
function (2nd and 3rd years prior to death) was used to
model the incidence rate ratio of hospitalisation for each
cause of death adjusted for gender, indigenous status, co-
morbidity, age at death, hospital type, socio-economic
status, locational disadvantage and admission status.
These models were chosen over the Poisson model due to
over dispersion of the data (last year of life) and over dis-
persion plus a high frequency of zero counts of hospital
episodes (2nd and 3rd years prior to death).
Results
Characteristics of the data
Of the 43,812 individuals with a mortality record between
1997 and 2000, 39,099 (89.2%) had at least one hospital
episode. Of the hospital episodes recorded for those indi-
viduals, 4.4% (16,752) pertained to intra hospital trans-
fers, leaving the 39,099 individuals to utilise 364,638
separate episodes of care. Of the total number of individ-
uals with a mortality record, 32% (13,781) were eligible
for inclusion in the study because they died of one of the
five conditions of interest. These patients utilised 88,499
episodes of hospital care in the last three years of life, with
only 9% (1,268) not having at least one episode of hospi-
talisation. The distribution of individuals and episodes
amongst the five causes of death for the three look-back
periods are shown in table 1.BMC Health Services Research 2006, 6:74 http://www.biomedcentral.com/1472-6963/6/74
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Independent effects of socioeconomic status on the 
incidence rate ratio of hospitalisation
The independent effects of socio-economic status on the
rate of hospitalisation across the five causes of death are
shown in figure 1. The effect of socio-economic status was
dependant upon both the cause and time to death. For
those who died of colorectal cancer significantly higher
rates of hospitalisation were generally observed in both
the second and third year prior to death in highly advan-
taged individuals compared with the rates in individuals
from lower socioeconomic groups (advantaged to highly
disadvantaged). However, in the last year of life no signif-
icant difference (p ≥ 0.05) in incidence rates across levels
of socio-economic disadvantage were observed.
In those who died of lung cancer, socioeconomic status
was not generally associated with different hospital utili-
sation, except in highly disadvantaged individuals, who in
the last year of life had significantly lower utilisation rates
(IRR 0.85 95%CI 0.75 – 0.96). In those who died of breast
cancer, highly disadvantaged individuals had a signifi-
cantly increased rate of hospitalisation in the last year of
life (IRR 1.27 95%CI 1.04 – 1.52). However, no signifi-
cant difference (p ≥ 0.05) in rate was observed in the sec-
ond or third year prior to death.
Hospital utilisation appeared to be correlated with socio-
economic status in individuals who died of ischaemic
heart disease. An exception to this trend was observed in
highly disadvantaged individuals, where in both the sec-
ond (IRR 1.16 95% CI 0.84 – 1.60)) and third years (IRR
0.96 95% CI 0.67 – 1.37) prior to death the highest hos-
pitalisation rates were observed. In those who died of cer-
ebro- vascular disease, socioeconomic status showed no
consistent association with utilisation.
Independent effects of locational accessibility to services 
on the incidence rate ratio of hospitalisation
The independent effects of locational accessibility to serv-
ices on hospitalisation rates across the five causes of death
are shown in figure 2. Generally, locational accessibility to
services had less effect on the incidence rate of hospitali-
sation than socio-economic status. In those who died of
colorectal cancer, breast cancer or cerebro-vascular disease
no significant difference (p ≥ 0.05) in hospital utilisation
was observed across levels of locational accessibility.
However, significantly higher rates of hospitalisation (IRR
2.05 95%CI 1.21–3.45) were observed in the second year
prior to death in individuals who died of lung cancer and
lived in very remote areas, and in both the second (IRR
1.65 95%CI 1.52–1.80) and third (IRR 1.69 95%CI 1.54–
1.86) years prior to death in individuals who died of
ischaemic heart disease and lived in inner regional areas.
In addition, significantly lower hospitalisation rates (IRR
0.72 95%CI 0.56–0.92) were observed in the last year of
life in individuals living in very remote areas who died of
ischaemic heart disease.
Independent effects of private patient status on the 
incidence rate ratio of hospitalisation
The independent effects of private patient status on the
rate of hospitalisation across the five causes of death are
shown in figure 3. Similar to the results observed for
socio-economic status, the separate effect of private
patient status was variable and strongly dependant upon
both the cause of and time to death. The incidence rate of
'no hospital admission' in all of the three cancers for pri-
vately insured patients was significantly different (p ≥
0.05) from the rate of no admission for public patients
across all three look-back periods. However, in those who
died of ischaemic heart disease and cerebro-vascular dis-
ease the rate of no admission for private versus public
patients was only significantly different in the last year of
life.'
For individuals who died of colorectal cancer, private
admission rates were significantly higher (IRR 1.34
95%CI 1.20–1.49) in the last year of life compared with
public admission rates. Whereas in the third year prior to
death, private admission rates were significantly (p <
0.05) lower than public rates across all three cancers stud-
ied. For those who died of colorectal cancer admission
rates for the 'other' category were significantly lower than
public rates, regardless of time to death. However, this
Table 1: The distribution of individuals and episodes of hospitalisation across the five cause of death categories and three look-back 
periods
Last year of life 2ndyear prior to death 3rdyear prior to death
Cause of death Individuals Episodes Episodes Episodes
n% n% n% n%
Colorectal Cancer 1409 10.2 11127 23.1 5678 23.6 3151 19.3
Lung Cancer 2087 15.1 9338 19.4 2624 10.9 1521 9.3
Breast Cancer 754 5.5 5432 11.3 2689 11.2 1660 10.2
Ischaemic Heart Disease 7111 51.6 17268 35.9 10384 43.2 7809 47.8
Cerebro-Vascular Disease 2420 17.6 4963 10.3 2674 11.1 2181 13.4
Total 13,781 100 48,128 100 24,049 100 16,322 100BMC Health Services Research 2006, 6:74 http://www.biomedcentral.com/1472-6963/6/74
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pattern was not observed for those who died of lung or
breast cancer, where admission rates were generally not
significantly different (p ≥ 0.05) from public rates.
In individuals who died of cerebro-vascular disease, both
private and 'other' admission rates in the last year of life
were significantly higher (p < 0.05) than public admission
The independent effects of socio-economic disadvantage on the incidence rate of hospitalisation across five causes of death Figure 1
The independent effects of socio-economic disadvantage on the incidence rate of hospitalisation across five causes of death. 
IRR: Incidence rate ratio. All IRR's are corrected for gender, indigenous status, co-morbid conditions, hospital type, age at 
death, locational accessibility and admission status.
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rates. While in individuals who died of breast cancer both
private and 'other' admission rates were significantly
lower (p < 0.05) than public rates three years and one year
prior to death respectively. In contrast, individuals who
died of ischaemic heart disease only showed significantly
different rates of hospitalisation in the third year prior to
The independent effects of locational accessibility on the incidence rate of hospitalisation across five causes of death Figure 2
The independent effects of locational accessibility on the incidence rate of hospitalisation across five causes of death. IRR: Inci-
dence rate ratio. All IRR's are corrected for gender, indigenous status, co-morbid conditions, hospital type, age at death, socio-
economic status and admission status.
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The independent effects of private patient status on the incidence rate of hospitalisation across five causes of death Figure 3
The independent effects of private patient status on the incidence rate of hospitalisation across five causes of death. IRR: Inci-
dence rate ratio. All IRR's are corrected for gender, indigenous status, co-morbid conditions, hospital type, age at death, socio-
economic status and locational accessibility. *The category no hospital admission indicates the IRR of no hospital admission for 
private versus public patients in each look-back period.
Last year of life
2nd yr before death
3rd yr before death
Death due to Colorectal Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Ischaemic Heart Disease
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Lung Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Cerebrovascular Disease
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Breast Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Last year of life
2nd yr before death
3rd yr before death
Death due to Colorectal Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Colorectal Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
Death due to Colorectal Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Ischaemic Heart Disease
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Ischaemic Heart Disease
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Death due to Ischaemic Heart Disease
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Lung Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Lung Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
Death due to Lung Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Cerebrovascular Disease
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Cerebrovascular Disease
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Death due to Cerebrovascular Disease
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Breast Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
Death due to Breast Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
Death due to Breast Cancer
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
Public
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
0.00
0.50
1.00
1.50
2.00
2.50
No Hospital Admission* Private Other
I
R
R
 
o
f
 
H
o
s
p
i
t
a
l
i
s
a
t
i
o
n
PublicBMC Health Services Research 2006, 6:74 http://www.biomedcentral.com/1472-6963/6/74
Page 8 of 10
(page number not for citation purposes)
death, where 'other' admission rates were significantly
lower (p < 0.05) than public rates.
Discussion
In this study we have examined the independent effects of
socioeconomic, locational accessibility to services and pri-
vate patient status on hospital utilisation rates in the last
years of life in patients who died of the same underlying
cause after adjustment for potential confounders.
Although the literature is replete with studies recognising
that socioeconomic status has a marked effect on utilisa-
tion of health services, the majority of studies have been
subject to criticism due to potential confounding by sever-
ity of illness or comorbidity. For example, in a study
examining trends in patterns of hospitalisation of the
New South Wales population, Walker et al [20] found that
the poorest socioeconomic group had a 21% higher hos-
pitalisation rate in 1996/1997 compared with that
observed in the richest sub group, an association which
was reversed for private patients. However, in that study
no adjustment was made for severity of illness or comor-
bidity, nor was stratification by disease attempted. Thus it
is difficult to determine if the differential utilisation was
explained by structural differences such as variations in
social support or by real differences in need, or both.
Other studies have looked at access to specialised services
as a function of socioeconomic status. Coory et al [21]
investigated the effects of socioeconomic status on utilisa-
tion of invasive coronary procedures in Queensland. The
authors found, as has been demonstrated in numerous
other studies, wide disparities in access. They concluded
that free access to health care did not necessarily ensure
equitable access. However, in that study there was no
adjustment for severity of illness, although adjustment
was made for comorbidity, for this reason the results
reported by Coory et al [21] were unable to assess equity
issues definitively, given that equity requires 'equal access
for equal need'.
Studies that have assessed health outcome as a function of
socioeconomic status have found an inverse relationship
between socioeconomic status and mortality. Hall et al
[22] examined the influence of social, economic and loca-
tional disadvantage on lung and breast cancer case fatality
in Western Australia, finding that survival was poorer in
patients treated in public hospitals, rural hospitals and
relatively disadvantaged socioeconomic groups. The
authors acknowledged that since no staging information
was available, adjustment for severity of disease was not
possible.
In this study, in addition for adjusting for demographic
characteristics and comorbidity, we have at least partially
adjusted for severity of illness by restricting the analyses
by both the time to death and underlying cause so as to
generate, as far as possible, a relatively homogenous
group of patients with respect to need. Further, we have
accounted for the possibility that patients from disadvan-
taged groups may have a shorter average duration of life-
threatening illness due to more advanced disease at initial
diagnosis, by undertaking separate analyses for the last,
second and third year prior to death. Given that in the last
year of life needs will most likely be the most homoge-
nous, any differences between the utilisation rate in that
period for a particular cause of death is more likely to be
attributable to causes other than illness severity rather
than differences observed in the second or third years
prior to death. Therefore, comparison of utilisation trends
across socio-demographic variables between look-back
periods has enabled us to separate severity of illness
effects from true socio-demographic effects.
Our results suggest that the independent effects of socioe-
conomic status differ markedly across diseases and that
the consistency of effects between three and one-year
observation periods before death also differs across dis-
eases. For colorectal cancer we observed no significant
socioeconomic effect in the last year of life; however, in
the third year prior to death socioeconomic status had a
statistically significant effect suggesting that disease sever-
ity may have confounded the effect of socioeconomic sta-
tus observed earlier in the course of the disease. This
would be consistent, for example, with a screening effect
of higher rates of colonoscopy leading to higher and ear-
lier hospital utilisation in more advantaged groups. For
lung, breast cancer and ischaemic heart disease the reverse
association was observed with respect to highly disadvan-
taged individuals. In the third year prior to death no sta-
tistically significant difference was observed for between
highly disadvantaged and highly advantaged individuals,
but in the last year of life a marked difference was
observed, suggesting that socioeconomic status is a major
driver of differential utilisation. Such differential hospital
utilisation in terminal breast cancer patients might, for
example, be due to a lower level of accessibility to hospice
or home-based palliative care services.
With respect to disadvantaged, average and advantaged
individuals who died of ischaemic heart disease we found
that utilisation was associated with socioeconomic advan-
tage regardless of time to death indicating that socioeco-
nomic status was the major driver of differential
utilisation. Severity of illness did not appear to confound
this association because there was little difference in
results across look-back periods. The effect of socioeco-
nomic status in cerebrovascular disease was difficult to
interpret since the relationship was inconsistent across
disadvantage categories.BMC Health Services Research 2006, 6:74 http://www.biomedcentral.com/1472-6963/6/74
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Distance to health services has long been recognised as an
important factor in access to care with numerous studies
describing an inverse relationship between distance and
utilisation across many diseases. Jong et al [8] showed that
people living in areas of Australia with limited access to
services had poorer health than people living in metropol-
itan areas. Jones et al [5] examined the relationship
between asthma mortality and access to health services,
finding that asthma mortality increased with travel time
to hospital. An inverse relationship between geographic
proximity to services and mortality has also been demon-
strated for ischaemic heart disease in Australia. Sexton et
al [6] found that populations living outside capital cities
had higher death rates than those living in capital cities in
Australia. In addition, Hall et al [12] found that locational
accessibility had a significant effect on patterns of surgical
care in people with colorectal cancer and the mortality of
patients with breast and lung cancer [22]. As has been the
case with socioeconomic status, a major limitation of all
of these studies was the lack of adjustment for severity of
illness and often comorbidity as well.
Our results suggest that locational accessibility to services
is generally not an independent predictor of utilisation
during the years leading up to death, with the exception of
in those dying from ischaemic heart disease, where we
found that the incidence rate ratios were significantly dif-
ferent in the last year of life. These results are somewhat
concordant with a study of colorectal and lung cancer
which suggested that disease stage accounted for differen-
tial utilisation effects rather than locational accessibility
per se [23].
It has been suggested that the existence of optional private
health insurance in addition to the universal publicly
funded Medicare system in Australia has led to a two tier
system, for the rich and poor, with implications for treat-
ment patterns and survival in economically disadvan-
taged groups [24]. However, proponents of the dual
system argue that private health insurance is able to fund
extra demands in a regulated way by providing a mecha-
nism to ensure choice in service provision and reducing
pressures on the public system [25]. Our results indicate
that admission as a private patient (adjusted for hospital
type, locational accessibility and socioeconomic status)
did not consistently effect utilisation across all causes of
death. However, we found that payment classification had
a statistically significant independent effect when colorec-
tal cancer or cerebrovascular disease was the underlying
cause of death and that in both cases the effect was most
marked in the last year of life when we found that private
patients were more likely to be hospitalised.
Strengths and limitations of this study
The use of probabilistically matched administrative
health data made available a comprehensive patient-
based data set, as opposed to a separations-based data set,
enabling access to historical information on health service
utilisation for the total population of WA. The study was
therefore population-based rather than sample-based;
allowing the health experience of all individuals who died
between 01/01/1997 and 31/12/2000 to be incorporated
into the modelling process. We feel this is likely to lead to
greater accuracy and improved external validity compared
with studies using institutional or response-based sam-
pling from a base population [26,27].
Significant information error in our results is highly
unlikely as the data used were population-based and clas-
sification regimes were applied consistently throughout
the data set. Exhaustive validation research on the WA
Data Linkage System [15] has shown that missing demo-
graphic data items are very uncommon (<1%). One limi-
tation of our study is that we used time to death as a proxy
for severity of illness, which was in itself a proxy for level
of need. The measurement of severity of illness is a major
problem when undertaking studies of this type as it can-
not be readily determined from administrative data sets.
Our use of time to death defined a relatively homogenous
group of patients and this, combined with stratification
by underlying cause of death, may have reduced the extent
of confounding by stage of disease. However, the level of
control of confounding was likely to have been incom-
plete.
Conclusion
Our study has demonstrated that within a health system
that already supports universal access through Medicare,
the Australian hospital system is not equitable since equal
need does not equate to equal utilisation. The largest
inequity appears to be related to socioeconomic status,
while a moderate level of inequity exists in relation to pri-
vate patient status. Our results allude to marked variations
in the influence of socioeconomic, locational and private
patient status across causes of death, suggesting that
equity in hospital utilisation is not universal but rather is
disease specific, a finding that has not been identified pre-
viously in the literature.
Since it appears that the magnitude and direction of
socially-determined differences in health care utilisation
are both inconsistent and disease-specific. A 'one-size-fits-
all' approach to further improvements in equity may be
over simplistic. Thus initiatives beyond Medicare should
be devised and evaluated in relation to specific areas of
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